Fate Therapeutics: Q2 Earnings Snapshot

Barchart · 3d ago

SAN DIEGO (AP) — SAN DIEGO (AP) — Fate Therapeutics Inc. (FATE) on Thursday reported a loss of $30.2 million in its second quarter.

The San Diego-based company said it had a loss of 25 cents per share.

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 28 cents per share.

The clinical-stage biotech company that develops stem cell treatments posted revenue of $2.1 million in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FATE at https://www.zacks.com/ap/FATE